Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02401048
Title A Multi-Center Study of Ibrutinib in Combination With MEDI4736 in Subjects With Relapsed or Refractory Lymphomas
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Pharmacyclics
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Site-0397 Birmingham Alabama 35294 United States Details
Site-0047 Duarte California 91010 United States Details
Site-0038 Stanford California 94305 United States Details
Site-0388 Miami Florida 33136 United States Details
Site-0126 Chicago Illinois 60637 United States Details
Site-0020/0173 Boston Massachusetts 02114 United States Details
Site-0729 Ann Arbor Michigan 48109 United States Details
Site-0130 Detroit Michigan 48201 United States Details
Site-0343 Hackensack New Jersey 07601 United States Details
Site-0402 Philadelphia Pennsylvania 19104 United States Details
Site-0114 Seattle Washington 98104 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field